Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 35, Pages 4624-4634
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1038/onc.2014.392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of STAT3 in Thyroid Cancer
- (2014) Nadiya Sosonkina et al. Cancers
- Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice
- (2013) Dmytro Starenki et al. CANCER LETTERS
- Mitochondria-Targeted Nitroxide, Mito-CP, Suppresses Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo
- (2013) Dmytro Starenki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Mortalin/HSPA9-Mediated Switch in Tumor-Suppressive Signaling of Raf/MEK/Extracellular Signal-Regulated Kinase
- (2013) P.-K. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- Mitochondria: gatekeepers of response to chemotherapy
- (2013) Kristopher A. Sarosiek et al. TRENDS IN CELL BIOLOGY
- Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
- (2012) Madhavi Nagilla et al. ADVANCES IN THERAPY
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- SomaticRASMutations Occur in a Large Proportion of SporadicRET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon
- (2012) A. Boichard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS
- (2012) Nishant Agrawal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortalin–p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy
- (2011) W-J Lu et al. CELL DEATH AND DIFFERENTIATION
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells
- (2010) Dumrongkiet Arthan et al. CANCER LETTERS
- Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins - Identification of additional interacting regions
- (2010) Ohad Iosefson et al. FEBS LETTERS
- Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin
- (2010) Wen-Jing Lu et al. INTERNATIONAL JOURNAL OF CANCER
- The HSP70 chaperone machinery: J proteins as drivers of functional specificity
- (2010) Harm H. Kampinga et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
- (2009) Seung-Keun Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation